{"title": "Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2016-03-10", "cleaned_text": "December 04, 2018 | [Nora Samaranayake](mailto:nsamaranayake@ihv.umaryland.edu) Contact Institute of Human Virology Nora Samaranayake Chief Communications & Public Affairs Officer (443) 823-0613 (phone) (410) 706-1952 (fax) [nsamaranayake@ihv.umaryland.edu](mailto:nsamaranayake@ihv.umaryland.edu) Related stories Monday, July 17, 2023 [Researchers from the Institute of Human Virology Discover that a Bacterial Protein Causes Genomic Instability and Contributes to Reduced Fertility, and Birth Defects](https://www.medschool.umaryland.edu/news/2023/Researchers-from-the-Institute-of-Human-Virology-Discover-that-a-Bacterial-Protein-Causes-Genomic-Instability-and-Contributes-to-Reduced-Fertility-and-Birth-Defects.html) A team of researchers from the University of Maryland School of Maryland's (UMSOM) Institute of Human Virology (IHV), a Center of Excellence of the Global Virus Network (GVN), published new findings that emphasize the crucial role of the urinary and genital tract microbiota in adverse pregnancy outcomes and genomic instability that originate in the womb during fetal development. Tuesday, March 28, 2023 [Two-Time Lasker Awardee and Internationally Acclaimed Virologist, Robert C. Gallo, MD, To Step Down as Director of UM School of Medicine's Institute of Human Virology (IHV)](https://www.medschool.umaryland.edu/news/2023/Two-Time-Lasker-Awardee-and-Internationally-Acclaimed-Virologist-Robert-C-Gallo-MD-To-Step-Down-as-Director-of-UM-School-of-Medicines-Institute-of-Human-Virology-IHV.html) Robert C. Gallo, MD, one of the world's leading virologists and cancer researchers, announced he has stepped down from his position as Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), effective March 24. Wednesday, November 09, 2022 [Lishan Su, PhD, Invested as the UMSOM Charles Gordon Smith Endowed Professor for HIV Research](https://www.medschool.umaryland.edu/news/2022/Lishan-Su-PhD-Invested-as-the-UMSOM-Charles-Gordon-Smith-Endowed-Professor-for-HIV-Research.html) With his 92-year-old mother watching via live stream from the city of Qingdao, China, and an in-person audience of friends and colleagues gathered in Westminster Hall, Lishan Su, PhD, an internationally prominent virologist and immunologist at the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV), was invested as the Charles Gordon Smith Endowed Professor for HIV Research. Dr. Su is a Professor in the Departments of Pharmacology and Microbiology & Immunology at UMSOM's IHV, who also serves as the Director of the Division of Virology, Pathogenesis, and Cancer at the Institute. Monday, October 31, 2022 [NCI Grants Awarded to IHV to Prevent Cancer and Improve Screening in Sub-Saharan Africa](https://www.medschool.umaryland.edu/news/2022/NCI-Grants-Awarded-to-IHV-to-Prevent-Cancer-and-Improve-Screening-in-Sub-Saharan-Africa.html) Institute of Human Virology (IHV) researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million. One award aims to reduce the incidence of lung cancer and other cancers associated with using tobacco in Botswana. The other is focusing on improving screening and treatment of anal precancer in Nigeria. Both grants will make use of existing HIV treatment and prevention infrastructure in low- and middle-income countries to reach people living with HIV who are most at risk for these particular types of cancers. Wednesday, December 01, 2021 [$6.5M Grant Awarded to Develop Treatment for Alcoholic Liver Disease-Associated Kidney Dysfunction](https://www.medschool.umaryland.edu/news/2021/65M-Grant-Awarded-to-Develop-Treatment-for-Alcoholic-Liver-Disease-Associated-Kidney-Dysfunction.html) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and MitoPower LLC (\"MitoPower\") were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institute on Alcohol Abuse and Alcoholism. The funds will support the development of MitoPower's lead compound, MP-04, for the treatment of kidney dysfunction due to alcoholic liver disease, a condition known as alcoholic liver disease-associated hepatorenal syndrome (HRS). The IHV, a Center of Excellence member of the Global Virus Network (GVN), will conduct first-in-human single and multiple ascending dose studies to test the safety of the compound, followed by a Phase 1b study in patients. Thursday, November 04, 2021 [University of Maryland School of Medicine Institute of Human Virology Researchers Receive $6.5M to Create African Big Data Hub Designed to Address Public Health and Pandemic Preparedness](https://www.medschool.umaryland.edu/news/2021/University-of-Maryland-School-of-Medicine-Institute-of-Human-Virology-Researchers-Receive-65M-to-Create-African-Big-Data-Hub-Designed-to-Address-Public-Health-and-Pandemic-Preparedness.html) Researchers at the University of Maryland School of Medicine (UMSOM)'s Institute of Human Virology (IHV), a Global Virus Network (GVN) Center of Excellence, have received $6.5 million from the U.S. National Institutes of Health (NIH) to streamline big data collection in Nigeria and South Africa in addressing public health needs of the COVID-19 and HIV pandemics. Monday, June 24, 2019 [UM School of Medicine's Institute of Human Virology Awarded $40 Million Grant to Conduct HIV Population Surveys](https://www.medschool.umaryland.edu/news/2019/UM-School-of-Medicines-Institute-of-Human-Virology-Awarded-40-Million-Grant-to-Conduct-HIV-Population-Surveys.html) Man Charurat, MD, Professor of Medicine, Director, Center for International Health, Education, and Biosecurity (CIHEB), and Director, Division of Epidemiology and Prevention, Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), has been awarded a five-year grant from the U.S. Centers for Disease Control and Prevention (CDC) to conduct HIV population-based HIV impact assessments worldwide to measure the progress towards the control of the HIV epidemic Thursday, March 21, 2019 [IHV Experts Researching Experimental Drug to Curb Opioid Cravings](https://www.medschool.umaryland.edu/news/2019/IHV-Experts-Researching-Experimental-Drug-to-Curb-Opioid-Cravings.html) Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings. Wednesday, March 06, 2019 [UMSOM Researcher Elected as Fellow to American Academy of Microbiology](https://www.medschool.umaryland.edu/news/2019/UMSOM-Researcher-Elected-as-Fellow-to-American-Academy-of-Microbiology.html) Richard Y. Zhao, Ph.D., Professor of Pathology and Associate Member of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), has been elected as a Fellow to the American Academy of Microbiology (AAM). AAM is an honorific leadership group within the American Society for Microbiology (ASM). Wednesday, September 19, 2018 [Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials](https://www.medschool.umaryland.edu/news/2018/Institute-of-Human-Virology-IHV-Awarded-12M-to-Combat-Opioid-Epidemic-Through-Clinical-Research-Trials.html) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health's (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress. Wednesday, March 21, 2018 [Dr. Robert Redfield, Co-Founder of the Institute of Human Virology at the University of Maryland School of Medicine, to Become CDC Director ](https://www.medschool.umaryland.edu/news/2018/Dr-Robert-Redfield-Co-Founder-of-the-Institute-of-Human-Virology-at-the-University-of-Maryland-School-of-Medicine-to-Become-CDC-Director.html) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) congratulates its co-founder and associate director, Robert R. Redfield, MD, on his appointment to be the next director of the U.S. Centers for Disease Control and Prevention (CDC). Tuesday, March 20, 2018 [UMSOM Cancer Expert at Institute of Human Virology Named Fellow of American Society of Clinical Oncology](https://www.medschool.umaryland.edu/news/2018/UMSOM-Cancer-Expert-at-Institute-of-Human-Virology-Named-Fellow-of-American-Society-of-Clinical-Oncology.html) Clement A. Adebamowo, BM, ChB, ScD, FWACS, FACS, Associate of Population Science at the Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine (UMSOM), and Professor of Epidemiology and Public Health, Institute of Human Virology, has been named a 2018 Fellow of the American Society of Clinical Oncology (ASCO). Wednesday, November 29, 2017 [To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo](https://www.medschool.umaryland.edu/news/2017/To-Mark-World-AIDS-Day-Institute-of-Human-Virology-Releases-Video-on-Dr-Robert-Gallo.html) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day, December 1. While many know Dr. Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo's life and legacy in its entirety, including his pioneering discovery of human retroviruses. Tuesday, November 22, 2016 [IHV Awarded $138M to combat HIV/AIDS in Africa & Launches Center for International Health, Education, & Biosecurity](https://www.medschool.umaryland.edu/news/2016/IHV-Awarded-138M-to-combat-HIVAIDS-in-Africa--Launches-Center-for-International-Health-Education--Biosecurity.html) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today more than $138 million in multiple five-year grants awarded by the Centers for Disease Control and Prevention to combat HIV/AIDS in Kenya, Tanzania, Zambia, and Nigeria. The Institute concurrently announced the formation of the IHV Center for International Health, Education, & Biosecurity (CIHEB), and its newly appointed director, Deus Bazira Mubangizi, DrPH, MBA, MPH, Assistant Professor of Medicine, Director, Center for Health, Education, & Biosecurity, Institute of Human Virology, University of Maryland School of Medicine. Tuesday, October 25, 2016 [\"A Call to End HIV/AIDS in America\" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post](https://www.medschool.umaryland.edu/news/2016/A-Call-to-End-HIVAIDS-in-America-IHV-Director-Dr-Robert-Gallos-Op-Ed-in-the-Huffington-Post.html) As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country's leaders to utilize the largest global health initiative in history - the President's Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic. Monday, August 22, 2016 [Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research](https://www.medschool.umaryland.edu/news/2016/Institute-of-Human-Virology-IHV-Awarded-144M-for-HIV-Vaccine-Research.html) The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection. Wednesday, April 13, 2016 [IHV Releases Data Supporting Community-Based Treatment Providers in Fight Against Hepatitis C](https://www.medschool.umaryland.edu/news/2016/IHV-Releases-Data-Supporting-Community-Based-Treatment-Providers-in-Fight-Against-Hepatitis-C.html) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine released data today at The International Liver Congress 2016 in Barcelona, Spain demonstrating that treatment for hepatitis C virus (HCV) can be provided safely and effectively within a community-based and non-specialist setting. Thursday, March 10, 2016 [UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds](https://www.medschool.umaryland.edu/news/2016/UM-SOM-Establishes-Two-Endowed-Professorships-Through-Private-Gifts-and-Matching-State-Funds.html) University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships - one in human virology and vaccine development, the other in surgical science and entrepreneurship. "}